Anders Krarup-Hansen

Anders Krarup-Hansen

Clinical Associate Professor

Member of:

  • Clinical Oncology


Publication year:
All
1 - 10 out of 34Page size: 10
Sort by: Title
  1. Published

    A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas

    Vitfell-Rasmussen, J., Judson, I., Safwat, A. A., Jones, R. L., Rossen, P. B., Lind-Hansen, M., Knoblauch, P. & Krarup-Hansen, Anders, 2016, In: Sarcoma. 2016, 9 p., 2090271.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study

    Hensley, M. L., Enserro, D., Hatcher, H., Ottevanger, P. B., Krarup-Hansen, Anders, Blay, J., Fisher, C., Moxley, K. M., Lele, S. B., Lea, J. S., Tewari, K. S., Thaker, P. H., Zivanovic, O., O'Malley, D. M., Robison, K. & Miller, D. S., 2018, In: Journal of Clinical Oncology. 36, 33, p. 1-9 JCO1800454.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)

    Eriksson, M., Reichardt, P., Joensuu, H., Krarup-Hansen, Anders, Hagberg, O., Hohenberger, P., Hagberg, H., Hansson, L., Foukakis, T., Pulkkanen, K., Bauer, S., Goplen, D., Blach Rossen, P. & Hall, K. S., 2021, In: ESMO Open. 6, 4, 6 p., 100217.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Comparative analysis of postoperative adjuvant radiotherapy in glioblastoma multiforme

    Gibas, K., Schultze, J., Krarup-Hansen, Anders, Schultka, S. & Kimmig, B., 2010, In: Strahlentherapie und Onkologie. 186, p. 117 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  5. Published

    Dosimetric and geometric evaluation of an open low-field magnetic resonance simulator for radiotherapy treatment planning of brain tumours

    Kristensen, B. H., Laursen, F. J., Logager, V., Geertsen, P. F. & Krarup-Hansen, Anders, 2008, In: Radiotherapy & Oncology. 87, 1, p. 100-109 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

    Judson, I., Verweij, J., Gelderblom, H., Hartmann, J. T., Schöffski, P., Blay, J., Kerst, J. M., Sufliarsky, J., Whelan, J., Hohenberger, P., Krarup-Hansen, Anders, Alcindor, T., Marreaud, S., Litière, S., Hermans, C., Fisher, C., Hogendoorn, P. C. W., dei Tos, A. P., van der Graaf, W. T. A. & European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, E. O. A. T. O. C. S. T. A. B. S. G., Apr 2014, In: Lancet Oncology. 15, 4, p. 415-423 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

    Tap, W. D., Papai, Z., Van Tine, B. A., Attia, S., Ganjoo, K. N., Jones, R. L., Schuetze, S., Reed, D., Chawla, S. P., Riedel, R. F., Krarup-Hansen, A., Toulmonde, M., Ray-Coquard, I., Hohenberger, P., Grignani, G., Cranmer, L. D., Okuno, S., Agulnik, M., Read, W., Ryan, C. W. & 8 others, Alcindor, T., Del Muro, X. F. G., Budd, G. T., Tawbi, H., Pearce, T., Kroll, S., Reinke, D. K. & Schöffski, P., Aug 2017, In: Lancet Oncology. 18, 8, p. 1089-1103 15 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients with Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial

    Tap, W. D., Wagner, A. J., Schöffski, P., Martin-Broto, J., Krarup-Hansen, A., Ganjoo, K. N., Yen, C. C., Abdul Razak, A. R., Spira, A., Kawai, A., Le Cesne, A., Van Tine, B. A., Naito, Y., Park, S. H., Fedenko, A., Pápai, Z., Soldatenkova, V., Shahir, A., Mo, G., Wright, J. & 2 others, Jones, R. L. & ANNOUNCE Investigators, A. I., 2020, In: J A M A: The Journal of the American Medical Association. 323, 13, p. 1266-1276 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study

    Blay, J. Y., Schöffski, P., Bauer, S., Krarup-Hansen, Anders, Benson, C., D’Adamo, D. R., Jia, Y. & Maki, R. G., 2019, In: British Journal of Cancer. 120, 11, p. 1026-1032 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function

    Krarup-Hansen, Anders, Fugleholm, Kåre, Helweg-Larsen, S., Hauge, E. N., Schmalbruch, H., Trojaborg, W. & Krarup, Christian, 1993, In: Brain. 116, p. 1017-1041

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 Next

ID: 925763